ARTICLE SUMMARY:
Every hour counts for patients at risk of developing sepsis, yet the diagnostic tests that help clinicians determine treatments don’t deliver results for days. Day Zero Diagnostics has taken on this challenge by combining whole genome sequencing, machine learning, and blood sample preparation tools.
At the 2017 meeting of AdvaMed, the medical device industry’s advocacy organization, young start-up Day Zero Diagnostics was chosen as this year’s MedTech Innovator Global Competition winner. To ‘Meet the Innovator’ watch this short video interview.
